Commonwealth legislation

Therapeutic Goods (Listing) Notice 2006 (No. 1)

RepealedCTH

This Act has been repealed and is no longer in force. It is retained for historical reference.

Jurisdiction

Commonwealth

Collection

legislative instrument

Plain English Summary

2/10 complexity

This notice temporarily allows oral preparations containing whole dried wakame seaweed (Undaria pinnatifida, excluding the holdfast) to be supplied in Australia as listed therapeutic goods, letting manufacturers, importers and retailers legally sell capsules, tablets or powders without prescription. It’s a temporary administrative measure that lasts only until the Therapeutic Goods Regulations are amended to permanently list the ingredient.

JSON API Health / NDIS / medicines

Deep dive

Want the full deep dive?

Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.

Current sections

Direct links to the current provisions in Therapeutic Goods (Listing) Notice 2006 (No. 1).

Therapeutic Goods (Listing) Notice 2006 (No. 1)

View image in the official source

Therapeutic Goods Act 1989

Therapeutic Goods (Listing) Notice 2006 (No. 1)

I, DAVID GRAHAM, National Manager, Therapeutic Goods Administration, delegate of the Minister for Health and Ageing for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (ARTG) for listed goods:

preparations, referred to in Item 3, Part 1 of Schedule 4 of the Therapeutic Goods Regulations 1990, for oral use that contain, as their therapeutically active ingredient, whole dried Undaria pinnatifida, excluding the holdfast, being a substance that is to be mentioned in Division 2 of Part 4 of Schedule 4 of the Therapeutic Goods Regulations 1990.

This Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.

Pursuant to subsection 9A(6) of the Act this Notice ceases to have effect on the day that amendments to the Therapeutic Goods Regulations 1990 come into effect to require inclusion of the substance(s) listed in this Notice in the part of the ARTG for listed goods.

Dated this seventh day of February 2006

(Signed)

Dr David Graham

Delegate of the Minister for Health and Ageing

Source text

Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.

1 Therapeutic Goods (Listing) Notice 2006 (No. 1)

Therapeutic Goods Act 1989

Therapeutic Goods (Listing) Notice 2006 (No. 1)

preparations, referred to in Item 3, Part 1 of Schedule 4 of the Therapeutic Goods Regulations 1990, for oral use that contain, as their therapeutically active ingredient, whole dried Undaria pinnatifida, excluding the holdfast, being a substance that is to be mentioned in Division 2 of Part 4 of Schedule 4 of the Therapeutic Goods Regulations 1990.

This Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.

Dated this seventh day of February 2006

(Signed)

Dr David Graham

Delegate of the Minister for Health and Ageing